The increasing prevalence of diabetes is the prime factor driving the growth of Non-Proliferative Diabetic Retinopathy market. However, lack of skilled professionals, extended approval time for drugs in conjunction with the strict regulatory requirements will restrict market growth.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: